Promises, pitfalls and practicalities of prenatal whole exome sequencing

Prenatal Diagnosis

Volumn 38, Issue 1, 2018, Pages 10-19

  Best, Sunayna ^a   Wou, Karen ^b   Vora, Neeta ^c   Van der Veyver, Ignatia B ^d   Wapner, Ronald ^b   Chitty, Lyn S ^a,e  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL DECISION MAKING; COMPARATIVE STUDY; DIAGNOSTIC VALUE; ECONOMIC ASPECT; ETHICS; FETUS DEVELOPMENT; FETUS DISEASE; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GENETIC VARIABILITY; HEALTH CARE COST; HEALTH PERSONNEL ATTITUDE; HUMAN; INCIDENTAL FINDING; NON INVASIVE PROCEDURE; NONHUMAN; PATIENT ATTITUDE; PHENOTYPE; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIORITY JOURNAL; SOCIAL ASPECT; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; CONGENITAL DISORDER; FEMALE; GENETICS; PREGNANCY; TRENDS;

CONGENITAL ABNORMALITIES; FEMALE; GENETIC DISEASES, INBORN; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; WHOLE EXOME SEQUENCING;

EID: 85026417835     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.5102     Document Type: Article

References (86)

1. Update on overall prevalence of major birth defects – Atlanta, Georgia, 1978–2005. MMWR Morb Mortal Wkly Rep. 2008;57:1–5.
2. Mathews TJ MM, MacDorman F, Thoma ME. Infant mortality statistics from the 2013 period linked birth/infant death data set. National Vital Statistics Reports [Internet]. 2015 08/03/2017; 64(9):[1–30 pp.]. Available from: https://www.cdc.gov/ncbddd/birthdefects/data.html.
3. Boyd PA, Tonks AM, Rankin J, et al. Monitoring the prenatal detection of structural fetal congenital anomalies in England and Wales: register-based study. J Med Screen 2011;18:2–7.
4. Calzolari E, Barisic I, Loane M, et al. Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study. Birth Defects Res A Clin Mol Teratol 2014;100:270–276.
5. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367:2175–2184.
6. Callaway JL, Shaffer LG, Chitty LS, et al. The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenat Diagn 2013;33:1119–1123.
7. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 2013;369:1502–1511.
8. Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 2015;519:223–228.
9. Chitty LS, Mason S, Barrett AN, et al. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn 2015;35:656–662.
10. Medeira A, Norman A, Haslam J, et al. Examination of fetuses after induced abortion for fetal abnormality – a follow-up study. Prenat Diagn 1994;14:381–385.
11. Willig LK, Petrikin JE, Smith LD, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med 2015;3:377–387.
12. Talkowski ME, Ordulu Z, Pillalamarri V, et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample. New Engl J Med. 2012;367:2226–2232.
13. Shamseldin HE, Swaid A, Alkuraya FS. Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing. Gen Med 2013;15:307–309.
14. Filges I, Nosova E, Bruder E, et al. Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype. Clin Genet 2014;86:220–228.
15. Drury S, Boustred C, Tekman M, et al. A novel homozygous ERCC5 truncating mutation in a family with prenatal arthrogryposis – further evidence of genotype-phenotype correlation. Am J Med Genet Part A 2014;164(A):1777–1783.
16. Wilbe M, Ekvall S, Eurenius K, et al. MuSK: a new target for lethal fetal akinesia deformation sequence (FADS). J Med Genet 2015;52:195–202.
17. Kan A, Au PKC, Li M, et al. Exome sequencing on a family with 3 pregnancies affected by central nervous system malformation identified a novel stop mutation in WDR81. Prenat Diagn 2015;35(Suppl 1):71.
18. Casey J, Flood K, Ennis S, et al. Intra-familial variability associated with recessive RYR1 mutation diagnosed prenatally by exome sequencing. Prenat Diagn 2016;36:1020–1026.
19. Romagnoli MPE, Palombo F, Bonara E, Seri M. RYR1 related congenital myopathy in two sib fetuses conceived through artificial insemination with donor sperm (AID). Eur J Hum Genet 2016;24(E-Suppl 1):–26.
20. Alamillo C, Kobari J, Powis Z, et al. Clinical Diagnostic Exome Sequencing Identified Compound Heterozygous ASPM Gene Alterations in a Fetus with Marked Microcephaly. Presented at ACMG Annual Clinical Genetics Meeting: Tampa, Florida; 2016 https://acmg.expoplanner.com/index.cfm?do=expomap.sess&event_id=7&session_id=1505.
21. Kooper AHW, Smeets D, Lugtenberg D, et al. Prenatal diagnosis of a rare, autosomal recessive disorder by combining genome wide array analysis and whole exome sequencing. Prenat Diagn 2016;36(Suppl 1):76.
22. Yates CL, Monaghan KG, Copenheaver D, et al. Whole-exome sequencing on deceased fetuses with ultrasound anomalies: expanding our knowledge of genetic disease during fetal development. Genet Med 2017; https://doi.org/10.1038/gim.2017.31. [Epub ahead of print].
23. Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med 2016;18:696–704.
24. Carss KJ, Hillman SC, Parthiban V, et al. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet 2014;23:3269–3277.
25. Alamillo CL, Powis Z, Farwell K, et al. Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies. Prenat Diagn 2015;35:1073–1078.
26. Drury SES, Boustred C, Jenkins L, Chitty L. Prenatal diagnosis of sonographic abnormalities using rapid whole exome sequencing. Prenat Diagn 2016;36(Suppl. 1):51.
27. Vora NL, Brandt A, Strande N, et al. Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges. Genet Med 2017; in press.
28. Wapner RPS, Brennan K, Bier L, et al. Whole exome sequencing in the evaluation of fetal structural anomalies: a prospective study of sequential patients. Am J Obstet Gynecol 2017;216:S5–S6 http://www.ajog.org/article/S0002-9378(16)30988-7/fulltext.
29. McMullan DJ, Eberhardt R, Rinck G, et al. Exome Sequencing of 406 Parental/Fetal Trios with Structural Abnormalities Revealed by Ultrasound in the UK Prenatal Assessment of Genomes and Exomes (PAGE) Project. European Society of Human Genetics Copenhagen: Denmark; 2017.
30. Yadava SM, Ashkinadze E. 125: Whole exome sequencing (WES) in prenatal diagnosis for carefully selected cases. Am J Obstet Gynecol 2017;216:S87–S88 http://www.ajog.org/article/S0002-9378(16)31008-0/fulltext.
31. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014;312:1870–1879.
32. Drury S, Williams H, Trump N, et al. Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn 2015;35:1010–1017.
33. Pangalos C, Hagnefelt B, Lilakos K, Konialis C. First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects. PeerJ 2016;4: e1955.
34. Walkiewicz M, Braxton A, Liu P, Xia PF, Bi W, Xiao R et al. The utility of whole exome sequencing in prenatal diagnosis. Presented at the American Society of Human Genetics Annual Meeting, 2016 in Vancouver. https://ep70.eventpilot.us/web/planner.php?id=ASHG16
35. Barnett CP, Byrne A, Moore L, Khong Y, Manton N, Lipsett J et al. The genomic autopsy: using whole exome and whole genome sequencing to solve complex fetal and neonatal presentations. Presented at the American Society of Human Genetics Annual Meeting, 2016 in Vancouver. https://ep70.eventpilot.us/web/planner.php?id=ASHG16
36. Ryan E, Friedman B, Haskins A, Barbar R, Nelson Z, Al-Musafri F et al. Whole exome sequencing in 129 fetuses with abnormal ultrasound findings. Presented at ACMG Annual Clinical Genetics Meeting; Phoenix, Arizona2017. https://acmg.expoplanner.com/index.cfm?do=expomap.sess&event_id=8&session_id=5012
37. Sá J, Melo F, Tarelho A, et al. Broad multi-gene panel or whole exome sequencing in malformed fetuses reveals eight definitive and one likely diagnoses in fifteen studied fetus, in prenatal setting. ESHG 2017; https://2017.eshg.org/index.php/abstracts-2/online-planner-abstract-search/.
38. Joset P, Wisser J, Niedrist D, et al. Mendeliome and whole exome sequencing in 60 fetuses with abnormal ultrasound revealed a diagnostic yield of 30%. ESHG 2017; https://2017.eshg.org/index.php/abstracts-2/online-planner-abstract-search/.
39. Skirton H, Goldsmith L, Jackson L, et al. Offering prenatal diagnostic tests: European guidelines for clinical practice. Eur J Hum Genet 2014;22:580–586.
40. Illsinger S, Das AM. Impact of selected inborn errors of metabolism on prenatal and neonatal development. IUBMB Life 2010;62:403–413.
41. Natarajan N, Tully HM, Chapman T. Prenatal presentation of pyruvate dehydrogenase complex deficiency. Pediatr Radiol 2016;46:1354–1357.
42. Robinson JN, Norwitz ER, Mulkern R, et al. Prenatal diagnosis of pyruvate dehydrogenase deficiency using magnetic resonance imaging. Prenat Diagn 2001;21:1053–1056.
43. Sofou K, Dahlin M, Hallbook T, et al. Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J Inherit Metab Dis 2017;40:237–245.
44. McGivern MR, Best KE, Rankin J, et al. Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study. Arch Dis Child Fetal Neonatal Ed 2015;100:F137–F144.
45. Arzt W, Tulzer G. Fetal surgery for cardiac lesions. Prenat Diagn 2011;31:695–698.
46. Stoll C, Clementi M. Prenatal diagnosis of dysmorphic syndromes by routine fetal ultrasound examination across Europe. Ultrasound Obstet Gynecol 2003;21:543–551.
47. Westgren M, Götherström C. Stem cell transplantation before birth – a realistic option for treatment of osteogenesis imperfecta? Prenat Diagn 2015;35:827–832.
48. Chitty LS, David AL, Gottschalk I, et al. BOOSTB4: a clinical study to determine safety and efficacy of pre- and/or postnatal stem cell transplantation for treatment of osteogenesis imperfecta. Ultrasound Obstet Gynecol 2016;48:356.
49. Fujikura K, Setsu T, Tanigaki K, et al. Kif14 mutation causes severe brain malformation and hypomyelination. PLoS One 2013;8: e53490.
50. Filges I, Friedman JM. Exome sequencing for gene discovery in lethal fetal disorders – harnessing the value of extreme phenotypes. Prenat Diagn 2015;35:1005–1009.
51. Westerfield L, Darilek S, van den Veyver IB. Counseling challenges with variants of uncertain significance and incidental findings in prenatal genetic screening and diagnosis. J Clin Med 2014;3:1018–1032.
52. Kalia SS, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017;19:249–255.
53. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565–574.
54. Johnston JJ, Rubinstein WS, Facio FM, et al. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes. Am J Hum Genet 2012;91:97–108.
55. Ross LF, Saal HM, David KL, Anderson RR. Technical report: ethical and policy issues in genetic testing and screening of children. Genet Med 2013;15:234–245.
56. Borry P, Evers-Kiebooms G, Cornel MC, et al. Genetic testing in asymptomatic minors: background considerations towards ESHG recommendations. Eur J Hum Genet 2009;17:711–719.
57. Botkin JR, Belmont JW, Berg JS, et al. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 2015;97:6–21.
58. Kearney HM, Thorland EC, Brown KK, et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med 2011;13:680–685.
59. Green RC, Berg JS, Berry GT, et al. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med medicine 2012;14:405–410.
60. Landrum MJ, Lee JM, Benson M, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 2016;44(D1):D862–D868.
61. Stenson PD, Mort M, Ball EV, et al. The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 2017;136(6):665–677.
62. MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014;508:469–476.
63. Blaas HG. Detection of structural abnormalities in the first trimester using ultrasound. Best Pract Res Clin Obstet Gynaecol 2014;28:341–353.
64. Cavoretto P, Giorgione V, Cipriani S, et al. Nuchal translucency measurement, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: systematic review and meta-analysis. Prenat Diagn 2017;37(6):540–555.
65. Benjamini Y, Speed TP. Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res 2012;40(10): e72.
66. ACMG. Board of Directors. Points to consider for informed consent for genome/exome sequencing. Genet Med 2013;15:748–749.
67. Committee Opinion no. 682. Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools. Obstet Gynecology 2016;128:1462–1463.
68. Gardiner C WD, Kilby M, Kerr B. Recommendations for the use of chromosome microarray in pregnancy 2015 16/12/2016. Available from: http://www.bsgm.org.uk/media/956141/g144_useofcmapregnancy_jun15.pdf.
69. Sabatini LM, Mathews C, Ptak D, et al. Genomic sequencing procedure microcosting analysis and health economic cost-impact analysis: a report of the Association for Molecular Pathology. J Mol Diagn 2016;18:319–328.
70. Beckmann JS. Can we afford to sequence every newborn baby's genome? Hum Mutat 2015;36(3):283–286.
71. Sboner A, Mu XJ, Greenbaum D, et al. The real cost of sequencing: higher than you think! Genome Biol 2011;12:125.
72. Horn R, Parker M. Opening Pandora's box: ethical issues in prenatal whole genome and exome sequencing. Prenat Diagn 2017;in press.
73. Yurkiewicz IR, Korf BR, Lehmann LS. Prenatal whole-genome sequencing – is the quest to know a fetus's future ethical? N Engl J Med 2014;370:195–197.
74. Kalynchuk EJ, Althouse A, Parker LS, et al. Prenatal whole-exome sequencing: parental attitudes. Prenat Diagn 2015;35:1030–1036.
75. Quinlan-Jones E, Kilby MD, Greenfield S, et al. Prenatal whole exome sequencing: the views of clinicians, scientists, genetic counsellors and patient representatives. Prenat Diagn 2016;36:935–941.
76. Bayefsky MJ, White A, Wakim P, et al. Views of American OB/GYNs on the ethics of prenatal whole-genome sequencing. Prenat Diagn 2016;36:1250–1256.
77. Drury S, Mason S, McKay F, et al. Implementing non-invasive prenatal diagnosis (NIPD) in a National Health Service Laboratory; from dominant to recessive disorders. Adv Exp Med Biol 2016;924:71–75.
78. Fan HC, Gu W, Wang J, et al. Non-invasive prenatal measurement of the fetal genome. Nature 2012;487(7407):320–324.
79. Kitzman JO, Snyder MW, Ventura M, et al. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 2012;4(137):137ra76.
80. Van den Veyver IB. Recent advances in prenatal genetic screening and testing. F1000Research. 2016;5:2591.
81. Tabor HK, Murray JC, Gammill HS, Kitzman JO, Snyder MW, Ventura M, et al. Non-invasive fetal genome sequencing: opportunities and challenges. Am J Med Genet 2012;158 A(10):2382–2384.
82. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. New Engl J Med 2013;369:1502–1511.
83. Aggarwal STA, Das Bhowmik A, Dalal A. From fetal dysmorphology to exome sequencing: the diagnostic performance for making a perinatal genetic diagnosis. Prenat Diagn 2016;36(Suppl.1):19.
84. Black HA, Parry D, Atanur SS, et al. De novo mutations in autosomal recessive congenital malformation. Genet Med 2016;18:1325–1326.
85. Pinto AM, Imperatore V, Bianciardi L, et al. Combined ultrasound and exome sequencing approach recognizes Opitz G/BBB syndrome in two malformed fetuses. Clin Dysmorphol 2017;26:18–25.
86. Gijsbers ACJ, Smeets D, Pfundt R, et al. Severe ultrasound abnormalities: prenatal whole exome sequencing to unravel a diagnosis before birth. ESHG 2017; https://2017.eshg.org/index.php/abstracts-2/online-planner-abstract-search/. Accessed 08/06/2017.